Host defense functions of pulmonary surfactant

Biology of the Neonate

Volumn 85, Issue 4, 2004, Pages 326-332

  Wright, Jo Rae ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Collectins; Immunity; Pulmonary surfactants; Surfactant protein A; Surfactant protein D

Indexed keywords

ANTIBODY; ANTIGEN; COLLAGEN; COLLECTIN; LECTIN; LIPID; LUNG SURFACTANT; PROTEIN; SUGAR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ADAPTATION; AIR; AMINO TERMINAL SEQUENCE; BACTERIUM; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CONFERENCE PAPER; DENDRITIC CELL; DISEASE PREDISPOSITION; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; LIQUID; LUNG ALVEOLUS SURFACE TENSION; LUNG INFECTION; LUNG INJURY; LYMPHOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUTROPHIL; NONHUMAN; OPSONIZATION; PATHOGENESIS; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE;

HUMANS; IMMUNITY; INFECTION; INFLAMMATION; LUNG; LUNG DISEASES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS;

BACTERIA (MICROORGANISMS);

EID: 3042575106     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078172     Document Type: Conference Paper

References (87)

1. Wright JR, Clements JA: Metabolism and turnover of lung surfactant. Am Rev Respir Dis 1987;135:426-444.
2. Weaver TE: Pulmonary surfactant-associated proteins. Gen Pharmacol 1988;19:361-368.
3. Voorhout WF, Veenendaaal T, Kuroki Y, Ogasawara Y, van Golde LMG, Geuze HJ: Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 1992;40:1589-1597.
4. Kalina M, Mason RJ, Shannon JM: Surfactant protein C is expressed in alveolar type II cells but not in Clara cells of rat lung. Am J Respir Cell Mol Biol 1992;6:594-600.
5. Wang JX, Souza P, Kuliszewski M, Tanswell AK, Post M: Expression of surfactant proteins in embryonic rat lung. Am J Respir Cell Mol Biol 1994;10:222-229.
6. Rubio S, Lacaze-Masmonteil T, Chailley-Heu B, Kahn A, Bourbon JR, Ducroc R: Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine. J Biol Chem 1995;270:12162-12169.
7. Lin Z, Phelps D, deMello D, Page M, Coltun W, Floros J: Both human SP-A1 and SP-A2 genes are expressed in small and large intestine. Am J Respir Crit Care Med 2000;161:A43.
8. Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U: Localization of lung surfactant protein D on mucosal surfaces in human tissue. J Immunol 2000;164:5866-5870.
9. Whitsett JA, Nogee LM, Weaver TE, Horowitz AD: Human surfactant protein B: Structure, function, regulation, and genetic disease. Physiol Rev 1995;75:749-757.
10. Hamvas A, Nogee LM, deMello DE, Cole FS: Pathophysiology and treatment of surfactant protein-B deficiency. Biol Neonate 1995;67:18-31.
11. Williams GD, Christodoulou J, Stack J, Symons P, Wert SE, Murrell MJ, Nogee LM: Surfactant protein B deficiency: Clinical, histological and molecular evaluation. J Paediatr Child Health 1999;35:214-220.
12. Crouch E, Wright JR: Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521-554.
13. Crouch E, Hartshorn K, Ofek I: Collectins and pulmonary innate immunity. Immunol Rev 2000;173:52-65.
14. Crouch EC: Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998;19:177-201.
15. Wright JR: Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
16. Crouch EC: Modulation of host-bacterial interactions by collectins. Am J Respir Cell Mol Biol 1999;21:558-561.
17. Lawson PR, Reid KB: The roles of surfactant proteins A and D in innate immunity. Immunol Rev 2000;173:66-78.
18. Janeway CA Jr: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54:1-13.
19. Lyons CR, Ball EJ, Towes GB, Weissler GC, Stastyn P, Lipscomb BF: Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol 1986;137:1173-1180.
20. Xing Z, Kirpalani H, Torry D, Jordana M, Gauldie J: Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue. Am J Pathol 1993;143:1009-1015.
21. Havenith CE, Breedijk AJ, Hoefsmit EC: Effect of Bacillus Calmette-Guerin inoculation on numbers of dendritic cells in bronchoalveolar lavages of rats. Immunobiology 1992;184:336-347.
22. Gong JL: Intraepithelial airway dendritic cells: A distinct subset of pulmonary dendritic cells obtained by microdissection. J Exp Med 1992; 175:797-807.
23. Sertl K, Takemura T, Tschachler E, Ferrans V, Kaliner M, Shevach E: Dendritic cells with antigen-presenting capability reside in airway epithelium, lung, parenchyma, and visceral pleura. J Exp Med 1986;163:436-451.
24. Holt PG, Schon-Hegrad MA, Oliver J: MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. J Exp Med 1988;167:262-274.
25. Lambrecht BN, Carro-Muino I, Vermaelen K, Pauwels RA: Allergen-induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats. Am J Respir Cell Mol Biol 1999;20:1165-1174.
26. Mellman I, Turley SJ, Steinman RM: Antigen processing for amateurs and professionals. Trends Cell Biol 1998;8:231-237.
27. Havenith CE, van Miert PP, Breedijk AJ, Beelen RH, Hoefsmit EC: Migration of dendritic cells into the draining lymph nodes of the lung after intratracheal instillation. Am J Respir Cell Mol Biol 1993;9:484-488.
28. Havenith CE, Breedijk AJ, van Miert PP, Blijleven N, Calame W, Beelen RH, Hoefsmit EC: Separation of alveolar macrophages and dendritic cells via autofluorescence: Phenotypical and functional characterization. J Leukoc Biol 1993;53:504-510.
29. van den Heuvel MM, Vanhee DD, Postmus PE, Hoefsmit EC, Beelen RH: Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. J Allergy Clin Immunol 1998;101:90-95.
30. Bellini A, Vittori E, Marini M, Ackerman V, Mattoli S: Intraepithelial dendritic cells and selective activation of Th2-like lymphocytes in patients with atopic asthma. Chest 1993;103:997-1005.
31. Gelfand EW: Essential role of T lymphocytes in the development of allergen-driven airway hyperresponsiveness. Allergy Asthma Proc 1998;19:365-369.
32. Masten BJ, Lipscomb MF: Dendritic cells: Pulmonary immune regulation and asthma. Monaldi Arch Chest Dis 2000;55:225-230.
33. Pabst R, Tschernig T: Lymphocytes in the lung: An often neglected cell. Numbers, characterization and compartmentalization. Anat Embryol (Berl) 1995;192:293-299.
34. Holt PG, Robinson BW, Reid M, Kees UR, Warton A, Dawson VH, Rese A, Sekon-Hegrad M, Papdimitriou JM: Extraction of immune and inflammatory cells from human lung parenchyma: Evaluation of an enzymatic digestion procedure. Clin Exp Immunol 1986;66:188-200.
35. Pabst R, Binns R: Lymphocytes migrate from the bronchoalveolar space to regional bronchial lymph nodes. Am J Respir Crit Care Med 1995;151:495-499.
36. Ansfield MJ, Kaltreider HB, Caldwell JL, Herskowitz FN: Hyporesponsiveness of canine bronchoalveolar lymphocytes to mitogens: Inhibition of lymphocyte proliferation by alveolar macrophages. J Immunol 1979;122:542-548.
37. Becker S, Harris DT, Koren HS: Characterization of normal human lung lymphocytes and interleukin-2-induced lung T cell lines. Am J Respir Cell Mol Biol 1990;3:441-448.
38. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG: Biased accumulation of T lymphocytes with 'memory'-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990;171:1123-1140.
39. Borron P, Veldhuizen RA, Lewis JF, Possmayer F, Caveney A, Inchley K, Mc Fadden RG, Fraher LJ: Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol 1996;15:115-121.
40. Borron P, McCormack FX, Elhalwagi BM, Chroneos ZC, Lewis JF, Zhu S, Wright JR, Shepherd VL, Possmayer F, Inchley K, Fraher LJ: Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol 1998;19:L679-L686.
41. Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ: Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 1998;161:4599-4603.
42. Holt PG: Alveolar macrophages. II. Inhibition of lymphocyte proliferation by purified macrophages from rat lung. Immunology 1979;37:429-436.
43. 1 and S phase. Am J Respir Cell Mol Biol 1992;6:658-666.
44. Seitzman GD, Sonstein J, Kim S, Choy W, Curtis JL: Lung lymphocytes proliferate minimally in the murine pulmonary immune response to intratracheal sheep erythrocytes. Am J Respir Cell Mol Biol 1998;18:800-812.
45. Saltini C, Richeldi L, Holroyd KJ, du Bois RM, Crystal RG: Lymphocytes; in Crystal RG, West JB, Barnes PJ, Chernick NS, Weibel ER (eds): The Lung: Scientific Foundations. New York, Raven Press, 1991, pp 459-482.
46. Strickland D, Kees UR, Holt PG: Regulation of T-cell activation in the lung: Alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 1996;87:250-258.
47. Poulter LW, Janossy G, Power C, Sreenan S, Burke C: Immunological/ physiological relationships in asthma: Potential regulation by lung macrophages. Immunol Today 1994;15:258-261.
48. Pinkston P, Bitterman PB, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308:793-800.
49. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR: Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997;158:4336-4340.
50. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA: Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Resp Cell Mol Biol 1999;20:279-286.
51. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR: Surfactant protein-A deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998;19:700-708.
52. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T: Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999;103:1015-1021.
53. Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, Wright JR: Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol 2000;278:L840-L487.
54. Greene K, Whitsett JA, Korfhagen TR, Fisher JH: SP-D expression regulates endotoxin mediated lung inflammation in vivo. Am J Resp Crit Care Med 2000;161:A515.
55. Stamme C, Wright JR: Surfactant protein A enhances interferon-y induced nitric oxide but inhibits LPS-induced nitric oxide alveolar macrophages. Am J Respir Crit Care Med 2000;161:A515.
56. Hickman-Davis J, Gibbs-Erwin J, Lindsey JR, Matalon S: Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc Natl Acad Sci USA 1999;96:4953-4958.
57. Pasula R, Wright JR, Kachel DL, Martin WJ 2nd: Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 1999;103:483-490.
58. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM: By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003;115:13-23.
59. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX: Surfactant proteins A and D inhibit the growth of gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003;111:1589-1602.
60. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr: Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003;278:36250-36256.
61. Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, Harding CV, Wright JR: Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol 2001;281:L1453-L1463.
62. Brinker KG, Garner H, Wright JR: Surfactant protein A modualtes the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol 2003;284:L232-L241.
63. Wang JY, Shieh CC, You PF, Lei HY, Reid KB: Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 1998;158:510-518.
64. Cheng G, Ueda T, Nakajima H, Nakajima A, Kinjyo S, Motojima S, Fukuda T: Suppressive effects of SP-A on ionomycin-induced IL-8 production and release by eosinophils. Int Arch Allergy Immunol 1998;117:59-62.
65. Hermans C, Bernard A: Lung epithelium-specific proteins. Am J Respir Crit Care Med 1999;159:646-678.
66. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA 3rd, Hudson LD, Maunder RJ, Crim C, Hyers TM: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-1981.
67. Pison U, Obertacke U, Seeger W, Hawgood S: Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest 1992;22:712-718.
68. Baughman RP, Sternberg RI, Hull W, Buchsbaum JA, Whitsett J: Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 1993;147:653-657.
69. McCormack FX, King TE, Voelker DR, Robinson PC, Mason RJ: Idiopathic pulmonary fibrosis: Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991;144:160-166.
70. Hamm H, Luhrs J, Guzman y Rotaeche J, Costabel U, Fabel H, Bartsch W: Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994;106:1766-1770.
71. Lesur O, Bernard AM, Begin RO: Clara cell protein (CC-16) and surfactant-associated protein A (SP-A) in asbestos-exposed workers. Chest 1996;109:467-474.
72. Cormier Y, Israel-Assayag E, Desmeules M, Lesur O: Effect of contact avoidance or treatment with oral prednisolone on bronchoalveolar lavage surfactant protein A levels in subjects with farmer's lung. Thorax 1996;51:1210-1215.
73. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S: Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860-1866.
74. Kramer HJ, Schmidt R, Gunther A, Becker G, Suzuki Y, Seeger W: ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1995;152:1540-1544.
75. Govan JR, Deretic V: Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996;60:539-574.
76. Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO: Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 1999;20:90-98.
77. Griese M, Birrer P, Demirsoy A: Pulmonary surfactant in cystic fibrosis. Eur Respir J 1997; 10:1983-1988.
78. Griese M, von Bredow C, Birrer P: Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha-1-protease inhibitor in cystic fibrosis. Electrophoresis 2001;22:165-171.
79. Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, Lewandoski J, Zimmerman JJ: Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest 2000;118:164-174.
80. Hull J, South M, Phelan P, Grimwood K: Surfactant composition in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:161-165.
81. Vanderzwan J, McCaig L, Mehta S, Joseph M, Whitsett J, McCormack DG, Lewis JF: Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia. Eur Respir J 1998;12:1388-1396.
82. Mariencheck WM, Wright JR: A metalloproteinase secreted by Pseudomonas aeruginosa degrades pulmonary surfactant protein A (SPA). Am J Resp Crit Care Med 1999;159:A506.
83. Griese M, von Bredow C, Birrer P, Schams A: Inhalation of alpha(1)-protease inhibitor in cystic fibrosis does not affect surfactant convertase and surface activity. Pulm Pharmacol Ther 2001;14:461-467.
84. Prince A: Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract. Microb Pathog 1992;13:251-260.
85. Khubchandani KR, Oberley RE, Snyder JM: Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells. Am J Respir Cell Mol Biol 2001;25:699-706.
86. Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR: Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:576-585.
87. Madan T, Kishore U, Shah A, Eggleton P, Strong P, Wang JY, Aggrawal SS, Sama PU, Reid KB: Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 1997;110:241-249.